Joseph L. Goldstein

Professor & Chairman-Molecular Genetics Department at The University of Texas - Southwestern Medical Center

Joseph L. Goldstein

Joseph L. Goldstein

Professor & Chairman-Molecular Genetics Department at The University of Texas - Southwestern Medical Center

Overview
RelSci Relationships

3822

Number of Boards

21

Birthday

04/18/1940

Age

80

Number of Awards

4

Relationships
RelSci Relationships are individuals Joseph L. Goldstein likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Founder & Director at Peloton Therapeutics, Inc.

Relationship likelihood: Strong

President at Stanford University

Relationship likelihood: Strong

President at The Rockefeller University

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder at Genetics Institute LLC

Relationship likelihood: Strong

President Emeritus at California Institute of Technology

Relationship likelihood: Strong

Co-Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Director, Jan & Dan Duncan Neurological Research Institute at Texas Children's Hospital

Relationship likelihood: Strong

President Emeritus at Princeton University

Relationship likelihood: Strong

Chairman-Molecular Biology Department at The University of Texas - Southwestern Medical Center

Relationship likelihood: Strong

Paths to Joseph L. Goldstein
Potential Connections via
Relationship Science
You
Joseph L. Goldstein
Professor & Chairman-Molecular Genetics Department at The University of Texas - Southwestern Medical Center
Memberships
Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Member
Current

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

Foreign Member
Current

The Royal Society is a self-governing Fellowship of many of the world’s most distinguished scientists drawn from all areas of science, engineering, and medicine. The Society’s fundamental purpose, reflected in its founding Charters of the 1660s, is to recognise, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity. The Society has played a part in some of the most fundamental, significant, and life-changing discoveries in scientific history and Royal Society scientists continue to make outstanding contributions to science in many research areas. The Royal Society is the national Academy of science in the UK, and its core is its Fellowship and Foreign Membership, supported by a dedicated staff in London and elsewhere. The Fellowship comprises the most eminent scientists of the UK, Ireland and the Commonwealth.

Career History
Associate
1995 - Current

The Howard Hughes Medical Institute (HHMI) is a nonprofit medical research organization that ranks as one of the nation’s largest philanthropies. HHMI plays a prominent role in advancing biomedical research and science education in the United States. Founded in 1953 by aviator and industrialist Howard R. Hughes, HHMI is headquartered in Chevy Chase, Maryland, and employs more than 3,000 individuals across the U.S. HHMI has an endowment of $16.1 billion of which the Institute spent $800 million for research and distributed $119 million in grant support for science education in fiscal year 2012

Professor & Chairman-Molecular Genetics Department
1977 - Current

UT Southwestern Medical Center is distinctive for its overall quality and for the strength of its three core missions of education, research, and patient care. These mission components are highly interdependent; each is integral to and enhances the others.UT Southwestern consists today of three degree-granting schools and a University Health System of hospitals and clinics. Its faculty is renowned for including six Nobel Laureates (one now Emeritus) and many members of the National Academy of Sciences and Institute of Medicine, and UT Southwestern Medical Center is either nationally ranked or rated as high performing in nearly a dozen specialties by U.S. News & World Report.

Science Partner
Current

The Column Group invests primarily in the biotechnology sector with emphasis on disease-focused drug discovery companies in the areas of cancer, inflammation, infectious disease, metabolic disorders, cardiovascular disease and nervous system disorders. The firm looks for companies with big ideas that are backed by outstanding science and strong therapeutic pipeline potential. Companies must have innovative and compelling ideas and exceptional scientific and management teams. Investments range from $15 million to $30 million over the life of a company for seed and early-stage investments through to the later stages of development.

Boards & Committees
Member, Scientific Advisory Board
Prior

ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY.

Member, Science Advisory Board
Tenure Unconfirmed

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Member, Scientific Advisory Board
Current

Van Andel Institute provides biomedical research and education services. Its services include antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI.

Member, Scientific Advisory Board
Prior

Since 1811, Massachusetts General Hospital has been committed to delivering standard-setting medical care. Throughout the decades, the hospital has had a consistent commitment to advancing that care through pioneering research and educating future health care professionals. The third oldest general hospital in the United States and the oldest and largest hospital in New England, Mass General continues its tradition of excellence today. On July 17, 2012, Mass General was named America's best hospital by U. S. News & World Report based on our quality of care, patient safety and reputation in 16 different specialties. In 2008, Mass General was redesignated a Magnet hospital, the highest honor for nursing excellence awarded by the American Nurses Credentialing Center. World-Class Patient Care Our 907-bed medical center, located in the heart of Boston, offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery. We offer high-quality care and services in four health centers in the Boston area. The hospital also holds concurrent Level 1 verification for adult and pediatric trauma and burn care. Our five multidisciplinary care centers – known worldwide for innovations in cancer, digestive disorders, heart disease, transplantation and vascular medicine – unite specialists across the hospital to offer patients comprehensive, state-of-the-art medical care. In addition, through MassGeneral Hospital for Children, we provide a full range of pediatric health care services, from primary care to cutting-edge treatments of complex and rare disorders. A Research Powerhouse Mass General has long been a leader in successfully bridging innovative science with state-of-the-art clinical medicine. With an annual research budget of nearly $764 million, Mass General conducts the largest hospital-based research program in the United States - a program that spans more than 20 clinical departments and centers across the hospital. This funding drives discoveries and breakthroughs in basic and clinical research, which translate into new and better treatments that transform medical practice and patient care. Learn more about Mass General research. An Emphasis on Teaching Mass General is the original and largest teaching hospital of Harvard Medical School, where nearly all of our staff physicians serve on the faculty. Since the hospital’s founding, Mass General has been committed to training and mentoring the next generation of international leaders in science and medicine, providing a wealth of opportunities for physicians, nurses, allied health professionals, physical, occupational and speech and language therapists and other health professionals. These talented men and women, in turn, lend fresh and innovative perspective on how to treat and care for patients. See medical residency and fellowship opportunities at Mass General. Setting the Bar for Quality & Safety Safety, effectiveness, patient centeredness, timeliness, efficiency and equity – these six tenets established by the Institute of Medicine are the foundation of our approach to quality and safety. We measure our performance, set high goals and track our progress toward those goals. We compare ourselves against local and national benchmarks in key quality and safety areas to ensure we deliver the highest quality and safest care possible. Learn more about our quality and patient-safety programs. Reaching Out to the Community Our work has always been guided by the needs of patients and their families. Mass General partners with communities to build, improve and sustain health care delivery and increase the health and well-being of those who live and work and these communities. Read about how Mass General is making a difference locally and globally. At our main campus and four health centers in Charlestown, Chelsea, Revere and the North End, Mass General annually: Admits 47,000 inpatients Handles nearly 1.4 million outpatient visits Records 88,000 emergency room visits Performs 38,000 operations Delivers 3,600 babies Mass General is a founding member of Partners HealthCare, an integrated health care delivery system that includes the two founding academic medical centers, community hospitals, primary care and specialty physicians, specialty facilities, community health centers and other health-related entities. Our Mission Guided by the needs of our patients and their families, we aim to deliver the very best health care in a safe, compassionate environment; to advance that care through innovative research and education; and to improve the health and well-being of the diverse communities we serve

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2006

The New York Academy of Sciences is a membership organization with over 25,000 members in 140 countries. They include research scientists at universities and industry, as well as representatives of business, government, and policy organizations. Our Board of Governors and President's Council include 27 Nobel laureates and other prominent leaders of academia and industry, based in New York and around the world.

N/A
2006

The Cooper Institute operates a not for profit organization. It specializes in the scientific research of preventive medicine and public health. The company was founded by Kenneth H. Cooper in 1970 and is headquartered in Dallas, TX.

$1 - $999
2005

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Political Donations
$1,000
2010

Chairman, Lazard Houston at Lazard Ltd.

$1,200
2008

Former President of United States

$500
1996
Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2003
Albany Prize in Medicine and Biomedical Research
1988
United States - National Medal of Sciences
1985
Nobel Prize in Physiology or Medicine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Joseph L. Goldstein. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Joseph L. Goldstein's profile does not indicate a business or promotional relationship of any kind between RelSci and Joseph L. Goldstein.